Ladenburg Thalmann Financial Services’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$10K Sell
1,504
-7,756
-84% -$31.7K ﹤0.01% 4499
2019
Q3
$31K Buy
9,260
+2,310
+33% +$7.61K ﹤0.01% 3766
2019
Q2
$23K Buy
6,950
+690
+11% +$2K ﹤0.01% 3982
2019
Q1
$19K Sell
6,260
-654
-9% -$2.12K ﹤0.01% 4046
2018
Q4
$19K Buy
6,914
+54
+0.8% +$178 ﹤0.01% 3915
2018
Q3
$23K Sell
6,860
-2,000
-23% -$6.18K ﹤0.01% 3834
2018
Q2
$19K Hold
8,860
﹤0.01% 3872
2018
Q1
$19K Buy
8,860
+600
+7% +$1.35K ﹤0.01% 3872
2017
Q4
$16K Sell
8,260
-500
-6% -$1.09K ﹤0.01% 3938
2017
Q3
$28K Hold
8,760
﹤0.01% 3490
2017
Q2
$28K Hold
8,760
﹤0.01% 3405
2017
Q1
$25K Hold
8,760
﹤0.01% 3423
2016
Q4
$20K Buy
8,760
+500
+6% +$952 ﹤0.01% 3486
2016
Q3
$14K Hold
8,260
﹤0.01% 3640
2016
Q2
$9K Buy
8,260
+500
+6% +$483 ﹤0.01% 3854
2016
Q1
$7K Buy
+7,760
New +$7.51K ﹤0.01% 3921
2014
Q1
Sell
-500
Closed -$2K 3884
2013
Q4
$2K Hold
500
﹤0.01% 3538
2013
Q3
$2K Hold
500
﹤0.01% 3483
2013
Q2
$2K Buy
+500
New +$1.93K ﹤0.01% 3360

Other funds holding ATRS

Ladenburg Thalmann Financial Services's ATRS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Antares Pharma, Inc. (ATRS) stake by 84% in Q4 2019, selling an estimated $31.7K and leaving 1,504 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #4499.

Ladenburg Thalmann Financial Services first reported a position in ATRS in Q2 2013 and has held it in 19 quarters since. The position peaked at $31K in Q3 2019. 160 funds tracked by Wall St. Rank hold ATRS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,504 shares of Antares Pharma, Inc. worth $10K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 7,756 Antares Pharma, Inc. shares in Q4 2019, an estimated $31.7K.
  • Antares Pharma, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4499 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Antares Pharma, Inc. in Q2 2013 and has held it in 19 quarters since.
  • Ladenburg Thalmann Financial Services's Antares Pharma, Inc. position peaked at $31K in Q3 2019.
  • 160 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.